Cold News and Research

RSS

UK study reports on attitudes to COVID-19 symptoms and testing

Researchers from King’s College London and Public Health England studied how people engage with the NHSTT, in particular, how people recognize symptoms and get tested. They reported their results in a paper published on the medRxiv* preprint server.

4 Jun 2021

Optimized Tube Plate for Enzyme Studies

BioChromato Inc. has developed an enzyme assay product - the RAPID Tube Plate 600 (TP-600) that is helping deliver outstanding results in in vitro metabolic stability studies.

From BioChromato Inc. 3 Jun 2021

A novel multi-epitope COVID-19 vaccine developed using reverse vaccinology

A new study has been published in the Journal of Biomolecular Structure and Dynamics which focuses on the evaluation of E, M, N, ORF10, ORF8, ORF3a, and M proteins using bioinformatics tools to develop a multi-epitope COVID-19 vaccine. The researchers utilized in-silico methods to incite humoral and cellular immune responses.

31 May 2021

A call to action to share 2 billion doses of COVAX in 2021

Countries that are advanced in their vaccination programmes are seeing cases of COVID-19 decline, hospitalizations decrease and early signs of some kind of normality resume.

31 May 2021

Heart Failure 2021 to showcase latest evidence on prevention, management of heart failure

The latest evidence on the prevention and management of heart failure will be showcased at Heart Failure 2021, an online scientific congress of the European Society of Cardiology (ESC).

29 May 2021

Researcher investigates the behavior and life cycle of most infectious pathogenic bacteria

28 May 2021

Study may lead to new treatments that eliminate cancer cells without harming other body cells

Normal cells usually have multiple solutions for fixing problems. For example, when DNA becomes damaged, healthy white blood cells can use several different strategies to make repairs.

28 May 2021

Researchers discover cross-reactive coronavirus antibody triggered during COVID-19 infection

Even before the COVID-19 pandemic, most people in the United States already had been sick with a coronavirus, albeit a far less dangerous one.

28 May 2021

New DNA COVID-19 vaccine proven effective in mice

A new study has shown that a new DNA-based COVID-19 vaccine successfully induced immunization against SARS-CoV-2 in mice and hamsters.

27 May 2021

Light-controlled on/off switch helps control biological clock in cultured cells, explanted tissue

The biological clock is present in almost all cells of an organism. As more and more evidence emerges that clocks in certain organs could be out of sync, there is a need to investigate and reset these clocks locally.

27 May 2021

Will SARS-CoV-2 eventually become just another seasonal coronavirus?

Could SARS-CoV-2 become just a seasonal nuisance in the next decade, causing just coughs and sniffles like a common cold, suggests new research? Scientists at the University of Utah, USA, tried to predict the possible future of the novel coronavirus using mathematical models that use learnings from the current pandemic on changes in human immunity over time.

26 May 2021

Immunologists decode T cell responses that occur during COVID-19 infection

An international team of researchers from the Institute for Research in Biomedicine, affiliated to the Università della Svizzera italiana, has deciphered, at single cell resolution, the T cell responses occurring during COVID-19 infection.

26 May 2021

Researchers develop a novel probiotic formulation with high anti-SARS-CoV-2 potency

A team of international scientists recently conducted a randomized clinical trial to assess the safety and efficacy profiles of a novel probiotic formulation in symptomatic coronavirus disease 2019 (COVID-19) patients. The findings indicate that the probiotic formulation is highly effective in reducing symptom severity in COVID-19 patients without causing any adverse events.

25 May 2021

A new model to prevent or manage caffeine withdrawal after surgery

Millions of people consume caffeine in coffee, tea, sodas and energy drinks, but when they go without, the withdrawal symptoms can include drowsiness, difficulty concentrating and intense headaches.

25 May 2021

New testing protocol for SARS-CoV-2 can process thousands of samples within 48 hours

Researchers at the Vienna BioCenter designed a testing protocol for SARS-CoV-2 that can process tens of thousands of samples in less than 48 hours. The method, called SARSeq, is published in the journal Nature Communications and could be adapted to many more pathogens.

25 May 2021

New peptide-like molecules could treat herpes, COVID-19, and the common cold

Among the powerful biochemicals of the human immune system, peptides are one of the best.

24 May 2021

Could saffron be an effective supplement for helping manage COVID-19?

A new study, published in the journal Cell Press, explores the potential use of saffron (Crocus sativus L.) as a drug supplement for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19).

24 May 2021

Novel broad-spectrum antiviral compounds effective against Zika and SARS-CoV-2

A research team at the University of Alberta, Canada, led by Dr. Daniel Limonta, has described two novel molecules with broad antiviral properties that are effective against a range of virus types, including SARS-CoV-2.

21 May 2021

Researchers speculate the low prevalence of COVID-19 in Japan

Protective immune memory--through B cells, which make antibodies, and/or T cells, which in the case of CD8+ T cells can kill virus-infected cells--can be induced by identical but also by related viruses.

20 May 2021

Protein-based vaccines against SARS-CoV-2 may provide advantages over mRNA-based vaccines

Researchers in the UK have developed a protein-based subunit vaccine directed against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that could serve as an alternative to the mRNA-based vaccines currently approved for protecting against coronavirus disease 2019 (COVID-19).

20 May 2021

Cold News and Research

UK study reports on attitudes to COVID-19 symptoms and testing

Optimized Tube Plate for Enzyme Studies

A novel multi-epitope COVID-19 vaccine developed using reverse vaccinology

A call to action to share 2 billion doses of COVAX in 2021

Heart Failure 2021 to showcase latest evidence on prevention, management of heart failure

Researcher investigates the behavior and life cycle of most infectious pathogenic bacteria

Study may lead to new treatments that eliminate cancer cells without harming other body cells

Researchers discover cross-reactive coronavirus antibody triggered during COVID-19 infection

New DNA COVID-19 vaccine proven effective in mice

Light-controlled on/off switch helps control biological clock in cultured cells, explanted tissue

Will SARS-CoV-2 eventually become just another seasonal coronavirus?

Immunologists decode T cell responses that occur during COVID-19 infection

Researchers develop a novel probiotic formulation with high anti-SARS-CoV-2 potency

A new model to prevent or manage caffeine withdrawal after surgery

New testing protocol for SARS-CoV-2 can process thousands of samples within 48 hours

New peptide-like molecules could treat herpes, COVID-19, and the common cold

Could saffron be an effective supplement for helping manage COVID-19?

Novel broad-spectrum antiviral compounds effective against Zika and SARS-CoV-2

Researchers speculate the low prevalence of COVID-19 in Japan

Protein-based vaccines against SARS-CoV-2 may provide advantages over mRNA-based vaccines

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News